Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 199 75 007.6 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Rizatriptan, gegebenenfalls in der Form eines pharmazeutisch annehmbaren Salzes, insbesondere Rizatriptanbenzoat |
54 | Title of basic patent | TIGZ | Imidazol-, Triazol- und Tetrazolderivate |
51 | IPC main class | ICM (ICMV) | C07D 403/06 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 403/14 (2006.01), C07D 403/04 (2006.01), C07D 409/04 (2006.01), C07D 401/14 (2006.01), A61K 31/41 (2006.01) |
94 | Start of term of protection | LB | Jan 25, 2012 |
94 | End of term of protection | LE | Aug 11, 2013 |
22 | DE application date | DAT | Jan 27, 1999 |
| Date of publication of application for a certificate | OT | Apr 22, 1999 |
| Date of publication of grant of certificate | PET | Aug 12, 2004 |
71/73 | Applicant/owner | INH | Merck Sharp & Dohme Ltd., Hertford Road, EN11 9BU Hoddesdon, Hertfordshire, GB |
74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE |
| Address for service | | Abitz & Partner Patentanwälte mbB, 81628 München, DE |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 692 22 329.0 |
68 | EP file number of basic patent | GEAKZ | 92 30 0617.5 |
43 | Date of first publication | EVT | Apr 22, 1999 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 43363.00.00 1998-09-25
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 43363.01.00 1998-09-25
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 43365.00.00 1998-09-25
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 43365.01.00 1998-09-25
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| College ter Beoordeling van Geneesmiddelen (CBG) NL UR21815 1998-02-11
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| College ter Beoordeling van Geneesmiddelen (CBG) NL UR21816 1998-02-11
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| College ter Beoordeling van Geneesmiddelen (CBG) NL UR21817 1998-02-11
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| College ter Beoordeling van Geneesmiddelen (CBG) NL UR21818 1998-02-11
|
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Dec 12, 2020 (Show all update days)(Hide all update days)- Dec 12, 2020; Jul 16, 2019; Jul 11, 2015; Jul 4, 2014; Mar 1, 2014; Nov 14, 2013; Sep 24, 2013; Sep 21, 2013; Sep 20, 2013; Apr 11, 2013; Mar 16, 2013; Mar 15, 2013; Mar 1, 2013; Jan 22, 2013; Jan 19, 2013; Jan 17, 2013; Dec 13, 2012; Dec 11, 2012; Nov 28, 2012; Nov 27, 2012; Nov 23, 2012; Oct 19, 2012; Oct 18, 2012; Sep 29, 2012; Sep 26, 2012; Sep 20, 2012; Sep 18, 2012; Sep 13, 2012; Sep 12, 2012; Sep 11, 2012; Sep 8, 2012; Aug 4, 2012; Aug 3, 2012; Jul 20, 2012; Jul 19, 2012; Jul 17, 2012; Jun 22, 2012; Jun 21, 2012; May 26, 2012; May 25, 2012; May 17, 2012; Apr 27, 2012; Apr 18, 2012; Apr 7, 2012; Mar 8, 2012; Mar 7, 2012; Mar 1, 2012; Feb 22, 2012; Feb 16, 2012; Feb 15, 2012; Feb 11, 2012; Feb 9, 2012; Feb 4, 2012; Feb 3, 2012; Jan 31, 2012; Nov 18, 2011; Nov 1, 2011; Sep 13, 2011; 31.05.2011; May 31, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|